Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.85 |
| ▸ | TSHR | P16473 | 5/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 5/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL421335 | 1.00 | MEN1 (0.85) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Hexaethylene Glycol SCHEMBL9719640 | 1.00 | MEN1 (0.85) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL21384854 | 1.00 | MEN1 (0.85) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL4603067 | 1.00 | MEN1 (0.85) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL16394863 | 0.96 | MEN1 (0.79) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL6249482 | 0.96 | MEN1 (0.79) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL444830 | 0.96 | MEN1 (0.79) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL8330422 | 0.96 | TSHR (0.83) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL8581564 | 0.96 | TSHR (0.83) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL486990 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11577454-B2 | Three-dimensional printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-02-14 | — | — | US | claimed |
| US-11331358-B2 | Pharmaceutical composition and method of manufacturing | SINDERBRAND LAW GROUP, PC | 2022-05-17 | — | — | US | disclosed |
| US-20200246406-A1 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | CURE PHARMACEUTICAL HOLDING CORP. (US) | 2020-08-06 | — | — | US | disclosed |
| US-10624940-B2 | Pharmaceutical composition and method of manufacturing | CURE PHARMACEUTICAL HOLDING CORP. (US) | 2020-04-21 | — | — | US | disclosed |
| US-20190209633-A1 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | SINDERBRAND LAW GROUP, PC | 2019-07-11 | — | — | US | disclosed |
| US-10125155-B2 | Silane modified formamides | COVESTRO DEUTSCHLAND AG (DE) | 2018-11-13 | — | — | US | disclosed |
| US-20180034055-A1 | COMPOSITE INCLUDING POROUS GRAPHENE AND CARBON NANOTUBE MATERIAL | University-Industry Foundation, Yonsei University (KR) | 2018-02-01 | — | — | US | disclosed |
| US-20160340371-A1 | SILANE MODIFIED FORMAMIDES | COVESTRO DEUTSCHLAND AG (DE) | 2016-11-24 | — | — | US | disclosed |
| US-20160280977-A1 | Two-Part Urethane Adhesive | IFS Industries Inc. | 2016-09-29 | — | — | US | disclosed |
| US-9221984-B2 | Cross-linked pigment dispersion based on polyurethane dispersants | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-29 | — | — | US | disclosed |
| US-20130102729-A1 | CROSS-LINKED PIGMENT DISPERSION BASED ON POLYURETHANE DISPERSANTS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-25 | — | — | US | disclosed |
| US-8361264-B2 | Process for producing polarizing plate, polarizing plate produced by the process, and liquid crystal display device using the polarizing plate | KONICA MINOLTA OPTO, INC. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110308712-A1 | PROCESS FOR PRODUCING POLARIZING PLATE, POLARIZING PLATE PRODUCED BY THE PROCESS, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE POLARIZING PLATE | KONICA MINOLTA OPTO, INC. (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110263741-A1 | SOFT POLYURETHANE FOAM WITH LOW RESILIENCE AND THE PREPARATION METHOD THEREOF | U CLEAN ASIA LIMITED (CN) | 2011-10-27 | — | — | US | disclosed |
| US-20100221457-A1 | OPTICAL COMPENSATION FILM, AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY EMPLOYING THE SAME | KONICA MINOLTA OPTO, INC. (JP) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10125155-B2 | Silane modified formamides | PFAS, ITGA8, NBAS | MEN1 752/4885KMT2A 119/4885TSHR 4873/4885 |
| US-20200246406-A1 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | CNR2, CNR1, CYP3A5 | MEN1 3386/4885KMT2A 2610/4885TSHR 4585/4885 |
| US-11331358-B2 | Pharmaceutical composition and method of manufacturing | CNR2, CNR1, CYP3A5 | MEN1 3386/4885KMT2A 2610/4885TSHR 4585/4885 |
| US-20160340371-A1 | SILANE MODIFIED FORMAMIDES | PFAS, ITGA8, NBAS | MEN1 695/4885KMT2A 118/4885TSHR 4870/4885 |
| US-20190209633-A1 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | CNR2, CNR1, CYP3A5 | MEN1 3386/4885KMT2A 2610/4885TSHR 4585/4885 |
| US-10624940-B2 | Pharmaceutical composition and method of manufacturing | CNR2, CNR1, CYP3A5 | MEN1 3386/4885KMT2A 2610/4885TSHR 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.